Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Toward the development of criteria for global flares in juvenile systemic lupus erythematosus.
Brunner HI, Klein-Gitelman MS, Higgins GC, Lapidus SK, Levy DM, Eberhard A, Singer N, Olson JC, Onel K, Punaro M, Schanberg L, von Scheven E, Ying J, Giannini EH. Brunner HI, et al. Among authors: olson jc. Arthritis Care Res (Hoboken). 2010 Jun;62(6):811-20. doi: 10.1002/acr.20126. Arthritis Care Res (Hoboken). 2010. PMID: 20535792 Free PMC article.
Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.
Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Lange M, Finck BK, Burge DJ; Pediatric Rheumatology Collaborative Study Group. Lovell DJ, et al. Among authors: olson jc. Arthritis Rheum. 2003 Jan;48(1):218-26. doi: 10.1002/art.10710. Arthritis Rheum. 2003. PMID: 12528122 Free article. Clinical Trial.
The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, Brunner HI, Griffin T, Graham TB, Sherry DD, Passo MH, Ramanan AV, Filipovich A, Grom AA. Bleesing J, et al. Arthritis Rheum. 2007 Mar;56(3):965-71. doi: 10.1002/art.22416. Arthritis Rheum. 2007. PMID: 17328073 Free article.
Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis.
Mamyrova G, O'Hanlon TP, Sillers L, Malley K, James-Newton L, Parks CG, Cooper GS, Pandey JP, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group. Mamyrova G, et al. Arthritis Rheum. 2008 Dec;58(12):3941-50. doi: 10.1002/art.24039. Arthritis Rheum. 2008. PMID: 19035492 Free PMC article.
Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis.
Giannini EH, Ilowite NT, Lovell DJ, Wallace CA, Rabinovich CE, Reiff A, Higgins G, Gottlieb B, Singer NG, Chon Y, Lin SL, Baumgartner SW; Pediatric Rheumatology Collaborative Study Group. Giannini EH, et al. Arthritis Rheum. 2009 Sep;60(9):2794-804. doi: 10.1002/art.24777. Arthritis Rheum. 2009. PMID: 19714630 Free article. Clinical Trial.
193 results